Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Hamilton

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
The Journal of Clinical Investigation|August 5, 2003
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virusBruno B Bordier, Junko Ohkanda, Ping Liu, et al.
Bioorganic & Medicinal Chemistry|November 24, 2004
In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeabilityDora Carrico, Junko Ohkanda, Howard Kendrick, et al.
Journal of Medicinal Chemistry|January 9, 2004
Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agentsJunko Ohkanda, Frederick S Buckner, Jeffrey W Lockman, et al.
European Journal of Medicinal Chemistry|July 16, 2014
Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)Madura K P Jayatunga, Sam Thompson, Tawnya C McKee, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2005
Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasitesMatthew P Glenn, Sung-Youn Chang, Oliver Hucke, et al.
Journal of Medicinal Chemistry|September 15, 2006
Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasitesMatthew P Glenn, Sung-Youn Chang, Carrie Hornéy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic TumorsAslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
Nature Communications|June 26, 2021
Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor functionL Palanikumar, Laura Karpauskaite, Mohamed Al-Sayegh, et al.
Journal of Medicinal Chemistry|September 9, 2010
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agentsSteven Fletcher, Erin Pusateri Keaney, Christopher G Cummings, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferaseWesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
The Journal of Clinical Investigation|August 5, 2003
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virusBruno B Bordier, Junko Ohkanda, Ping Liu, et al.
Bioorganic & Medicinal Chemistry|November 24, 2004
In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeabilityDora Carrico, Junko Ohkanda, Howard Kendrick, et al.
Journal of Medicinal Chemistry|January 9, 2004
Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agentsJunko Ohkanda, Frederick S Buckner, Jeffrey W Lockman, et al.
European Journal of Medicinal Chemistry|July 16, 2014
Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)Madura K P Jayatunga, Sam Thompson, Tawnya C McKee, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2005
Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasitesMatthew P Glenn, Sung-Youn Chang, Oliver Hucke, et al.
Journal of Medicinal Chemistry|September 15, 2006
Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasitesMatthew P Glenn, Sung-Youn Chang, Carrie Hornéy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic TumorsAslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
Nature Communications|June 26, 2021
Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor functionL Palanikumar, Laura Karpauskaite, Mohamed Al-Sayegh, et al.
Journal of Medicinal Chemistry|September 9, 2010
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agentsSteven Fletcher, Erin Pusateri Keaney, Christopher G Cummings, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferaseWesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
Pageof 18